17 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34472641 | Sulindac and vitamin D3 synergically inhibit proliferation of MCF-7 breast cancer cell through AMPK/Akt/β-catenin axis in vitro. | 2021 Dec | 2 |
2 | 32562844 | PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity. | 2020 Aug | 1 |
3 | 31571476 | Imaging and Inhibiting: A Dual Function Molecular Flare for Cancer Cells. | 2019 Nov 5 | 1 |
4 | 24675499 | The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac. | 2014 Jan-Feb | 2 |
5 | 24959268 | Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling. | 2014 Jul | 3 |
6 | 23804703 | Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling. | 2013 Sep | 1 |
7 | 22556201 | A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity. | 2012 Jun | 1 |
8 | 20470206 | Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation. | 2010 Jun | 6 |
9 | 18291362 | Sulindac suppresses beta-catenin expression in human cancer cells. | 2008 Mar 31 | 5 |
10 | 16546990 | Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways. | 2006 Mar | 3 |
11 | 16030090 | Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. | 2005 Jul | 3 |
12 | 16382042 | Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC. | 2005 Nov | 2 |
13 | 14610217 | The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells. | 2004 Feb | 1 |
14 | 14710233 | Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. | 2004 Jan 12 | 6 |
15 | 15476853 | beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention. | 2004 Nov 2 | 2 |
16 | 14555707 | Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. | 2003 Sep | 7 |
17 | 11751493 | Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. | 2001 Dec | 1 |